Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.1300 (0.39%) ($81.3500 - $86.0600) on Mon. Nov. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.46% (three month average) | RSI | 24 | Latest Price | $83.1300(0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.23% in a week (0% probabilities). VIXM(-22%) UUP(-17%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.23% (StdDev 2.46%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $68.6(-17.48%) | Inflection Point | Yes | Resistance Level | $91.79 | 5 Day Moving Average | $83.97(-1%) | 10 Day Moving Average | $84.34(-1.43%) | 20 Day Moving Average | $91.79(-9.43%) | To recent high | -30.2% | To recent low | 3.5% | Market Cap | $1.336b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |